Related Experiment Video
Updated: Nov 8, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Epidemiology, virology and clinical aspects of hantavirus infections: an overview
Sima Singh1, Arshid Numan2, Dinesh Sharma3
1Department of Pharmacy, University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, India.
Insights
Hantavirus infections, causing hemorrhagic renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), pose a growing global health threat. Effective treatments and vaccines are lacking, emphasizing the need for public awareness and preparedness.
Area of Science:
- * Infectious Diseases
- * Virology
- * Public Health
Background:
- * The COVID-19 pandemic highlighted global unpreparedness for communicable diseases.
- * Hantavirus infections represent a significant emerging public health concern.
- * Hantavirus, a zoonotic pathogen, causes severe diseases like HFRS and HCPS.
Purpose of the Study:
- * To review the epidemiology, virology, and clinical manifestations of Hantavirus.
- * To discuss current management strategies for HFRS and HCPS.
- * To enhance understanding of virus-host interactions for future outbreak preparedness.
Main Methods:
- * Comprehensive literature review of Hantavirus epidemiology, virology, and clinical presentations.
- * Analysis of existing management approaches for HFRS and HCPS.
- * Synthesis of current knowledge on virus-host interactions.
Main Results:
- * Hantavirus infections are a significant zoonotic threat with no current vaccines or effective treatments.
- * HFRS and HCPS are the primary clinical syndromes associated with Hantavirus.
- * Public awareness and precautionary measures are crucial for disease control.
Conclusions:
- * Enhanced understanding of Hantavirus is critical for effective public health response.
- * Further research into virus-host interactions may facilitate the development of treatments and vaccines.
- * Proactive preparedness is essential to manage Hantavirus outbreaks in a changing global health landscape.
Abstract:
At the end of 2019 and 2020s, a wave of coronavirus disease 19 (COVID-19) epidemics worldwide has catalyzed a new era of 'communicable infectious diseases'. However, the world is not currently prepared to deal with the growing burden of COVID-19, with the unexpected arrival of Hantavirus infection heading to the next several healthcare emergencies in public. Hantavirus is a significant class of zoonotic pathogens of negative-sense single-stranded ribonucleic acid (RNA). Hemorrhagic renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS) are the two major clinical manifestations. Till date, there is no effective treatments or vaccines available, public awareness and precautionary measures can help to reduce the spread of hantavirus disease. In this study, we outline the epidemiology, virology, clinical aspects, and existing HFRS and HCPS management approaches. This review will give an understanding of virus-host interactions and will help for the early preparation and effective handling of further outbreaks in an ever-changing environment.
Related Concept Videos
Viral Mutations
Introduction to Epidemiology

